RESEARCH LIBRARY
The published literature behind every Stellar formula.
Research is where formulation starts. This is the open reference layer — ingredient deep-dives, methodology essays, and the COA library where customers verify any batch by lot number.
WHY A RESEARCH LIBRARY
THE REFERENCE LAYER
Methodology is what we did. Research is the work that informed it.
Methodology pages document how Stellar formulates and verifies. Research is one layer beneath: the published clinical literature, ingredient context, and per-batch verification documents that the methodology rests on.
It's organized for the documentation-reader — the customer who looks up PMIDs before they read marketing.
The library expands as the line grows. New ingredients get deep-dive pages, new batches add COAs, and methodology essays are added as the framework evolves.
BROWSE BY TYPE
Three reference surfaces.
RESEARCH / INGREDIENTS
Ingredient deep-dives.
Per-ingredient pages with mechanism, dose-response evidence, safety profile, and references to the studies that informed the Stellar dose.
Browse ingredients →RESEARCH / ARTICLES
Methodology essays.
Long-form writing on how Stellar formulates, where our evidence review methodology came from, and what we're working through as the framework evolves.
Read essays →RESEARCH / COAS
COA library.
Lab-issued certificates of analysis for every production batch, accessible by lot number. Heavy metals, microbials, ingredient identity, active standardization.
Browse COAs →SHILAJIT MATRIX+
Every active. Every dose. The reasoning.
Tap any active to see why we chose the dose, the mechanism, and the studies the choice is anchored to. Amounts are per 2-capsule serving.
-
01 Shilajit fulvic complex 500mg
Why this dose
500 mg is the higher of the two doses in the human strength RCT (Keller 2019), the dose at which an effect was reported; that extract was standardized differently from ours. Our extract is standardized to 70% fulvic acid, verified per lot on the Certificate of Analysis.
Mechanism
Supports cellular energy production by contributing fulvic acid and dibenzo-α-pyrones implicated in CoQ10 transport.
Source(s)
-
02 Urolithin A 250mg
Why this dose
250 mg is inside the studied 10–1,000 mg/day range; the muscle and mitochondrial-gene outcomes were reported at 500–1,000 mg/day. Stated plainly.
Mechanism
Activates mitophagy — the cell's recycling process for damaged mitochondria.
Source(s)
-
03 Nicotinamide Riboside 150mg
Why this dose
Single doses of 100–1,000 mg raised the blood NAD+ metabolome dose-dependently; 150 mg is an NAD+-precursor amount inside that tested range, within a combined formula.
Mechanism
Serves as a precursor for NAD+ — a cofactor required by sirtuins and mitochondrial enzymes.
Source(s)
-
04 CoQ10 (ubiquinol) 200mg
Why this dose
200 mg per day of the reduced ubiquinol form sits in the human bioenergetic dose range; ubiquinol is selected for higher bioavailability than ubiquinone.
Mechanism
Electron transport in the mitochondrial respiratory chain.
Source(s)
-
05 PQQ 20mg
Why this dose
Held at the dose where a 2013 human study observed inflammation and mitochondrial-related metabolism shifts.
Mechanism
Cofactor implicated in mitochondrial biogenesis; reduces mitochondrial oxidative stress in vitro.
Source(s)
-
06 Astaxanthin 12mg
Why this dose
Dosed at 12 mg, toward the upper end of the 2–12 mg/day range used in human antioxidant trials; the exact per-lot amount is disclosed on the Certificate of Analysis.
Mechanism
Lipid-phase antioxidant with reported activity in cell membranes and mitochondrial inner membrane.
Source(s)
-
07 Alpha-Lipoic Acid (R-isomer) 125mg
Why this dose
Human ALA studies commonly use higher amounts (roughly 200–2,400 mg/day; PK studies used 500–600 mg). 125 mg is a supporting cofactor amount inside a combined formula; we do not claim it reproduces those higher-dose results.
Mechanism
Cofactor for mitochondrial enzymes; recycles other antioxidants in vivo.
Source(s)
-
08 Black pepper extract (BioPerine®) 10mg
Why this dose
Dosed at 10 mg (standardized to 95% piperine), the amount used in absorption-enhancement studies for co-administered actives; the exact per-lot amount is disclosed on the Certificate of Analysis.
Mechanism
Inhibits intestinal glucuronidation; can increase bioavailability of co-administered ingredients.
Source(s)
-
09 Apigenin 15mg
Why this dose
Included for its role in the NAD+ pathway. In cell and animal studies apigenin inhibits CD38, the main NAD+-consuming enzyme, which is why it sits beside nicotinamide riboside; the evidence is preclinical and is presented as rationale, not an outcome.
Mechanism
A chamomile/parsley flavone studied as a CD38 inhibitor in preclinical models.
Source(s)
-
10 Spermidine (wheat germ) 5mg
Why this dose
A polyamine studied alongside urolithin A for complementary autophagy and mitophagy roles. Stated plainly: controlled human pharmacokinetic work found 15 mg/day did not raise plasma spermidine and 40 mg/day was well tolerated; our amount is below both. Contains wheat.
Mechanism
Induces autophagy — the cell's recycling system.
Source(s)
PEER-REVIEWED REFERENCES
Studies our formulations are anchored to.
A non-exhaustive list of the published research that informed dose ranges, ingredient choices, and combinations across the Stellar line. Each entry links out to PubMed or the source journal.
3 of 3 references
-
01
View on PubMed →
MITOCHONDRIAL RENEWAL
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans.
-
02
View on PubMed →
NAD+ METABOLISM
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.
-
03
View on PubMed →
MITOCHONDRIAL FUNCTION
Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects.
No references match those filters.
Citations describe the topic of each study, not Stellar product claims. Stellar formulas are dietary supplements; structure/function statements have not been evaluated by the FDA. See the full DSHEA disclaimer in the footer.
COA LIBRARY
Per-batch certificates of analysis.
Searchable by SKU and lot number. Each batch's COA is published as a PDF. The lab partner's name and accreditation are documented per entry.
| SKU | Batch | Manufactured | Lab partner | COA |
|---|---|---|---|---|
|
COA LIBRARY PENDING The first batch's Certificate of Analysis lands here when verification completes. The library is searchable by SKU and lot number. |
||||
HOW THIS LIBRARY IS GOVERNED
Four reference principles.
01 · PRIMARY
Peer-reviewed first.
We anchor to peer-reviewed clinical research over secondary sources. PMIDs are linked where claims appear.
02 · TRACEABLE
Every batch is documented.
Each production lot has a COA on file. Customers can verify any unit by lot number.
03 · OPEN
Methodology is public.
Audit process, scoring criteria, and the per-claim source list are inspectable rather than walled-off.
04 · VERSIONED
Evolving, not fixed.
Methodology changes are dated and explained. When the framework improves, the change is logged here.
VERIFY
Look up any Stellar batch by lot.
Every production lot is documented at an independent ISO/IEC 17025 accredited lab. Customers can review the certificate of analysis.